German Christopher Paul bought RYTM

March 4, 2026 · Form 4 insider transaction

German Christopher Paul bought 1,500 shares of Rhythm Pharmaceuticals, Inc. at $17.97 per share, a transaction worth $27.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.